3.22.4 html 181 334 1 false 62 0 false 7 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.outlooktherapeutics.com/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 00100 - Statement - Consolidated Balance Sheets Sheet http://www.outlooktherapeutics.com/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.outlooktherapeutics.com/role/StatementConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 00200 - Statement - Consolidated Statements of Operations Sheet http://www.outlooktherapeutics.com/role/StatementConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.outlooktherapeutics.com/role/StatementConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 00400 - Statement - Consolidated Statements of Cash Flows Sheet http://www.outlooktherapeutics.com/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 10101 - Disclosure - Organization and Operations Sheet http://www.outlooktherapeutics.com/role/DisclosureOrganizationAndOperations Organization and Operations Notes 7 false false R8.htm 10201 - Disclosure - Liquidity Sheet http://www.outlooktherapeutics.com/role/DisclosureLiquidity Liquidity Notes 8 false false R9.htm 10301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 9 false false R10.htm 10401 - Disclosure - Fair Value Measurements Sheet http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 10501 - Disclosure - Property and Equipment Sheet http://www.outlooktherapeutics.com/role/DisclosurePropertyAndEquipment Property and Equipment Notes 11 false false R12.htm 10601 - Disclosure - Equity Method Investment Sheet http://www.outlooktherapeutics.com/role/DisclosureEquityMethodInvestment Equity Method Investment Notes 12 false false R13.htm 10701 - Disclosure - Accrued Expenses Sheet http://www.outlooktherapeutics.com/role/DisclosureAccruedExpenses Accrued Expenses Notes 13 false false R14.htm 10801 - Disclosure - Debt Sheet http://www.outlooktherapeutics.com/role/DisclosureDebt Debt Notes 14 false false R15.htm 10901 - Disclosure - Commitments and Contingencies Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 11001 - Disclosure - Stockholders' Equity Sheet http://www.outlooktherapeutics.com/role/DisclosureStockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 11101 - Disclosure - Preferred Stock Sheet http://www.outlooktherapeutics.com/role/DisclosurePreferredStock Preferred Stock Notes 17 false false R18.htm 11201 - Disclosure - Stock-Based Compensation Sheet http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 18 false false R19.htm 11301 - Disclosure - Collaboration Arrangements Sheet http://www.outlooktherapeutics.com/role/DisclosureCollaborationArrangements Collaboration Arrangements Notes 19 false false R20.htm 11401 - Disclosure - Related-Party Transactions Sheet http://www.outlooktherapeutics.com/role/DisclosureRelatedPartyTransactions Related-Party Transactions Notes 20 false false R21.htm 11501 - Disclosure - Income Taxes Sheet http://www.outlooktherapeutics.com/role/DisclosureIncomeTaxes Income Taxes Notes 21 false false R22.htm 20302 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 22 false false R23.htm 30303 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 23 false false R24.htm 30403 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurements 24 false false R25.htm 30503 - Disclosure - Property and Equipment (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosurePropertyAndEquipmentTables Property and Equipment (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosurePropertyAndEquipment 25 false false R26.htm 30703 - Disclosure - Accrued Expenses (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureAccruedExpenses 26 false false R27.htm 30803 - Disclosure - Debt (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureDebtTables Debt (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureDebt 27 false false R28.htm 30903 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingencies 28 false false R29.htm 31003 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureStockholdersEquity 29 false false R30.htm 31203 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensation 30 false false R31.htm 31503 - Disclosure - Income Taxes (Tables) Sheet http://www.outlooktherapeutics.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.outlooktherapeutics.com/role/DisclosureIncomeTaxes 31 false false R32.htm 40201 - Disclosure - Liquidity (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureLiquidityDetails Liquidity (Details) Details http://www.outlooktherapeutics.com/role/DisclosureLiquidity 32 false false R33.htm 40301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Info (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesInfoDetails Basis of Presentation and Summary of Significant Accounting Policies - Info (Details) Details http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 33 false false R34.htm 40302 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Dilutive (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDilutiveDetails Basis of Presentation and Summary of Significant Accounting Policies - Dilutive (Details) Details http://www.outlooktherapeutics.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 34 false false R35.htm 40401 - Disclosure - Fair Value Measurements (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurementsTables 35 false false R36.htm 40402 - Disclosure - Fair Value Measurements - Changes in fair value (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurementsChangesInFairValueDetails Fair Value Measurements - Changes in fair value (Details) Details 36 false false R37.htm 40403 - Disclosure - Fair Value Measurements - Assumptions (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureFairValueMeasurementsAssumptionsDetails Fair Value Measurements - Assumptions (Details) Details 37 false false R38.htm 40501 - Disclosure - Property and Equipment (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosurePropertyAndEquipmentDetails Property and Equipment (Details) Details http://www.outlooktherapeutics.com/role/DisclosurePropertyAndEquipmentTables 38 false false R39.htm 40601 - Disclosure - Equity Method Investment - Syntone (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureEquityMethodInvestmentSyntoneDetails Equity Method Investment - Syntone (Details) Details 39 false false R40.htm 40701 - Disclosure - Accrued Expenses (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureAccruedExpensesDetails Accrued Expenses (Details) Details http://www.outlooktherapeutics.com/role/DisclosureAccruedExpensesTables 40 false false R41.htm 40801 - Disclosure - Debt - Summary (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureDebtSummaryDetails Debt - Summary (Details) Details 41 false false R42.htm 40802 - Disclosure - Debt - Information (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureDebtInformationDetails Debt - Information (Details) Details 42 false false R43.htm 40803 - Disclosure - Debt - Maturities (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureDebtMaturitiesDetails Debt - Maturities (Details) Details 43 false false R44.htm 40901 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesTables 44 false false R45.htm 40902 - Disclosure - Commitments and Contingencies - Lease cost (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesLeaseCostDetails Commitments and Contingencies - Lease cost (Details) Details 45 false false R46.htm 40903 - Disclosure - Commitments and Contingencies - Lease balance sheet (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesLeaseBalanceSheetDetails Commitments and Contingencies - Lease balance sheet (Details) Details 46 false false R47.htm 40904 - Disclosure - Commitments and Contingencies - Lease cash flow (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesLeaseCashFlowDetails Commitments and Contingencies - Lease cash flow (Details) Details 47 false false R48.htm 40905 - Disclosure - Commitments and Contingencies - Lease minimum payments (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesLeaseMinimumPaymentsDetails Commitments and Contingencies - Lease minimum payments (Details) Details 48 false false R49.htm 40907 - Disclosure - Commitments and Contingencies - Employee Benefit (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCommitmentsAndContingenciesEmployeeBenefitDetails Commitments and Contingencies - Employee Benefit (Details) Details 49 false false R50.htm 41001 - Disclosure - Stockholders' Equity - Common Stock (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockholdersEquityCommonStockDetails Stockholders' Equity - Common Stock (Details) Details 50 false false R51.htm 41002 - Disclosure - Stockholders' Equity - Warrants (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockholdersEquityWarrantsDetails Stockholders' Equity - Warrants (Details) Details 51 false false R52.htm 41101 - Disclosure - Preferred Stock (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosurePreferredStockDetails Preferred Stock (Details) Details http://www.outlooktherapeutics.com/role/DisclosurePreferredStock 52 false false R53.htm 41201 - Disclosure - Stock-Based Compensation - Information (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensationInformationDetails Stock-Based Compensation - Information (Details) Details 53 false false R54.htm 41202 - Disclosure - Stock-Based Compensation - Expense (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensationExpenseDetails Stock-Based Compensation - Expense (Details) Details 54 false false R55.htm 41203 - Disclosure - Stock-Based Compensation - Stock option activity (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensationStockOptionActivityDetails Stock-Based Compensation - Stock option activity (Details) Details 55 false false R56.htm 41204 - Disclosure - Stock-Based Compensation - Option Assumptions (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensationOptionAssumptionsDetails Stock-Based Compensation - Option Assumptions (Details) Details 56 false false R57.htm 41205 - Disclosure - Stock-Based Compensation - Non-options (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensationNonOptionsDetails Stock-Based Compensation - Non-options (Details) Details 57 false false R58.htm 41206 - Disclosure - Stock-Based Compensation - Restricted stock (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureStockBasedCompensationRestrictedStockDetails Stock-Based Compensation - Restricted stock (Details) Details 58 false false R59.htm 41301 - Disclosure - Collaboration Arrangements (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureCollaborationArrangementsDetails Collaboration Arrangements (Details) Details http://www.outlooktherapeutics.com/role/DisclosureCollaborationArrangements 59 false false R60.htm 41401 - Disclosure - Related-Party Transactions (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureRelatedPartyTransactionsDetails Related-Party Transactions (Details) Details http://www.outlooktherapeutics.com/role/DisclosureRelatedPartyTransactions 60 false false R61.htm 41501 - Disclosure - Income Taxes (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) Details http://www.outlooktherapeutics.com/role/DisclosureIncomeTaxesTables 61 false false R62.htm 41502 - Disclosure - Income Taxes - Reconciliation tax expense (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureIncomeTaxesReconciliationTaxExpenseDetails Income Taxes - Reconciliation tax expense (Details) Details 62 false false R63.htm 41503 - Disclosure - Income Taxes - Deferred (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureIncomeTaxesDeferredDetails Income Taxes - Deferred (Details) Details 63 false false R64.htm 41504 - Disclosure - Income Taxes - Additional information (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureIncomeTaxesAdditionalInformationDetails Income Taxes - Additional information (Details) Details 64 false false R65.htm 41505 - Disclosure - Income Taxes - Unrecognized tax benefits (Details) Sheet http://www.outlooktherapeutics.com/role/DisclosureIncomeTaxesUnrecognizedTaxBenefitsDetails Income Taxes - Unrecognized tax benefits (Details) Details 65 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 28 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, otlk:PercentageOfCashBonusBasedOnSalary, otlk:TermOfContract, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:EarningsPerShareBasic, us-gaap:EarningsPerShareDiluted, us-gaap:OfficersCompensation, us-gaap:PreferredStockSharesOutstanding, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross, us-gaap:TemporaryEquitySharesOutstanding, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding, us-gaap:WeightedAverageNumberOfSharesOutstandingBasic - otlk-20220930x10k.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies - otlk-20220930x10k.htm 9 otlk-20220930x10k.htm otlk-20220930.xsd otlk-20220930_cal.xml otlk-20220930_def.xml otlk-20220930_lab.xml otlk-20220930_pre.xml otlk-20220930xex10d38.htm otlk-20220930xex21d1.htm otlk-20220930xex23d1.htm otlk-20220930xex31d1.htm otlk-20220930xex31d2.htm otlk-20220930xex32d1.htm otlk-20220930xex4d1.htm otlk-20220930x10k006.jpg otlk-20220930x10k007.jpg otlk-20220930x10k008.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true